论文部分内容阅读
从新药市场分析,用药的趋势表现为生活水平提高引起的营养过剩、工业化及社会竞争加剧所导致的精神疾患、以及提高生活质量的需求等几方面。增长较快的领域和品种包括HMG—CoA还原酶抑制剂、血管紧张素Ⅱ受体拮抗剂、COX-Ⅱ抑制剂、抗病毒药和碳青霉烯类抗生素。预计将要上市并有前景的新药有治疗心血管系统疾病的rosuvastatin,olmesartan,抗乙肝病毒药物adeforvir和entavavir以及碳青霉烯类药物CS-834。
From the analysis of the new drug market, the trend of drug use is manifested in several aspects such as excess nutrition caused by the improvement of living standards, industrialization and mental disorders caused by increased social competition, and the need to improve the quality of life. Fast-growing areas and varieties include HMG-CoA reductase inhibitors, angiotensin II receptor antagonists, COX-II inhibitors, antiviral drugs, and carbapenem antibiotics. New drugs that are expected to be marketed and are promising are rosuvastatin, olmesartan for the treatment of cardiovascular diseases, adeforvir and entavavir for hepatitis B, and CS-834 for carbapenems.